Coinfection with HIV and hepatitis C virus among injection drug users in Southern China

Clinical Infectious Diseases

Volumn 41, Issue 1 SUPPL., 2005, Pages

  Garten, Rebecca J ^a   Zhang, Jinbing ^a   Lai, Shenghan ^a   Liu, Wei ^b   Chen, Jie ^b   Yu, Xiao Fang ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Guangxi Centers for Disease Prevention and Control   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INJECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SUBSTANCE ABUSE; SUPERINFECTION; UNINDEXED SEQUENCE;

ADULT; BASE SEQUENCE; CHI-SQUARE DISTRIBUTION; CHINA; COHORT STUDIES; COMORBIDITY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MOLECULAR SEQUENCE DATA; MULTIVARIATE ANALYSIS; PHYLOGENY; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 20844432463     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/429491     Document Type: Article

References (32)

1. Verucchi G, Calza L, Manfredi R, Chiodo F. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection 2004; 32:33-46.
2. Zhang C, Yang R, Xia X, et al. High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China. J Acquir Immune Defic Syndr 2002; 29:191-6.
3. Ruan YH, Hong KX, Liu SZ, et al. Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China. World J Gastroenterol 2004; 10:1589-93.
4. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26:1-5.
5. Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284:450-6.
6. Bonacini M, Govindarajan S, Blatt LM, Schmid P, Conrad A, Lindsay KL. Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepat 1999; 6:203-8.
7. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001; 33:562-9.
8. Ragni MV, Belle SH. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis 2001; 183:1112-5.
9. Sabin CA, Telfer P, Phillips AN, Bhagani S, Lee CA. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J Infect Dis 1997; 175:164-8.
10. Piroth L, Duong M, Quantin C, et al. Does hepatitis C virus coinfection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 1998; 12:381-8.
11. Monga HK, Rodriguez-Barradas MC, Breaux K, et al. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 33:240-7.
12. Garten RJ, Lai S, Zhang J, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 2004; 33:182-8.
13. Laeyendecker O, Zhang GW, Quinn TC, et al. Molecular epidemiology of HIV-1 subtypes in Southern China. J Acquir Immune Defic Syndr 2005; 38:365-62.
14. Lai S, Liu W, Chen J, et al. Changes in HIV-1 incidence in heroin users in Guangxi Province, China. J Acquir Immune Defic Syndr 2001; 26:365-70.
15. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 2000; 182: 698-707.
16. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 1999; 41:95-8.
17. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25:4876-82.
18. Swofford DL. PAUP: Phylogenetic analysis using parsimony and other methods. Sunderland, MA: Sinauer Associates, 2001.
19. Posada D, Crandall KA. MODELTEST: testing the model of DNA substitution. Bioinformatics 1998; 14:817-8.
20. Thorpe LE, Quellet LJ, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002; 155:645-53.
21. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001; 91:42-6.
22. van Asten L, Verhaest I, Lamzira S, et al. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis 2004; 189:292-302.
23. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995; 171:1607-10.
24. Lau IY, Davis GL, Prescott LE, et al. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med 1996; 124:868-76.
25. Blatt LM, Mutchnick MG, Tong MJ, et al. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat 2000; 7:196-202.
26. Rai R, Wilson LE, Astemborski J, et al. Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology 2002; 35:1247-55.
27. Op de Coul EL, Prins M, Cornelissen M, et al. Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997. AIDS 2001; 15:257-66.
28. Simmonds P, Mellor J, Sakuldamrongpanich T, et al. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol 1996; 77: 3013-24.
29. Verachai V, Phutiprawan T, Theamboonlers A, et al. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand. Southeast Asian J Trop Med Public Health 2002; 33: 849-51.
30. Wang SM, Gao MY. Employment and contextual impact of safe and unsafe sexual practices for STI and HIV: the situation in China. Int J STD AIDS 2000; 11:536-44.
31. Beyrer C, Razak MH, Lisam K, Chen J, Lui W, Yu XF. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS 2000; 14:75-83.
32. Lai S, Chen I, Celentano D, et al. Adoption of injection practices in heroin users in Guangxi Province, China. J Psychoactive Drugs 2000; 32: 285-92.